372 related articles for article (PubMed ID: 8760828)
41. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
[TBL] [Abstract][Full Text] [Related]
42. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation.
Krasteva M; Kehren J; Horand F; Akiba H; Choquet G; Ducluzeau MT; Tédone R; Garrigue JL; Kaiserlian D; Nicolas JF
J Immunol; 1998 Feb; 160(3):1181-90. PubMed ID: 9570532
[TBL] [Abstract][Full Text] [Related]
43. Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency.
Kim JH; Kang TH; Noh KH; Bae HC; Ahn YH; Lee YH; Choi EY; Chun KH; Lee SJ; Kim TW
Clin Exp Immunol; 2011 Aug; 165(2):180-9. PubMed ID: 21592111
[TBL] [Abstract][Full Text] [Related]
44. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction.
Kato T; Hakamada R; Yamane H; Nariuchi H
J Immunol; 1996 May; 156(10):3932-8. PubMed ID: 8621933
[TBL] [Abstract][Full Text] [Related]
45. The antigen dose determines T helper subset development by regulation of CD40 ligand.
Ruedl C; Bachmann MF; Kopf M
Eur J Immunol; 2000 Jul; 30(7):2056-64. PubMed ID: 10940895
[TBL] [Abstract][Full Text] [Related]
46. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.
Balkow S; Loser K; Krummen M; Higuchi T; Rothoeft T; Apelt J; Tuettenberg A; Weishaupt C; Beissert S; Grabbe S
Exp Dermatol; 2009 Jan; 18(1):78-87. PubMed ID: 19054060
[TBL] [Abstract][Full Text] [Related]
47. Immunosuppressive components of Ascaris suum down-regulate expression of costimulatory molecules and function of antigen-presenting cells via an IL-10-mediated mechanism.
Silva SR; Jacysyn JF; Macedo MS; Faquim-Mauro EL
Eur J Immunol; 2006 Dec; 36(12):3227-37. PubMed ID: 17109466
[TBL] [Abstract][Full Text] [Related]
48. IL-12 induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10.
Huang LY; Reis e Sousa C; Itoh Y; Inman J; Scott DE
J Immunol; 2001 Aug; 167(3):1423-30. PubMed ID: 11466361
[TBL] [Abstract][Full Text] [Related]
49. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
50. CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.
Ribas A; Butterfield LH; Amarnani SN; Dissette VB; Kim D; Meng WS; Miranda GA; Wang HJ; McBride WH; Glaspy JA; Economou JS
Cancer Res; 2001 Dec; 61(24):8787-93. PubMed ID: 11751400
[TBL] [Abstract][Full Text] [Related]
51. Differential CD40/CD40L expression results in counteracting antitumor immune responses.
Murugaiyan G; Agrawal R; Mishra GC; Mitra D; Saha B
J Immunol; 2007 Feb; 178(4):2047-55. PubMed ID: 17277108
[TBL] [Abstract][Full Text] [Related]
52. IFN-beta differentially regulates CD40-induced cytokine secretion by human dendritic cells.
McRae BL; Beilfuss BA; van Seventer GA
J Immunol; 2000 Jan; 164(1):23-8. PubMed ID: 10604988
[TBL] [Abstract][Full Text] [Related]
53. Neuroblastoma-induced inhibition of dendritic cell IL-12 production via abrogation of CD40 expression.
Walker SR; Redlinger RE; Barksdale EM
J Pediatr Surg; 2005 Jan; 40(1):244-9; discussion 249-50. PubMed ID: 15868592
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the immunomodulatory effect of curdlan on maturation and function of mouse spleen-derived dendritic cells.
Soltani MH; Kalantari T; Karimi MH; Erfani N; Kamali Sarvestani E
Iran J Immunol; 2012 Sep; 9(3):168-74. PubMed ID: 23023381
[TBL] [Abstract][Full Text] [Related]
55. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
[TBL] [Abstract][Full Text] [Related]
56. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
Bishop GA; Warren WD; Berton MT
Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
[TBL] [Abstract][Full Text] [Related]
57. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells.
Iwasaki A; Kelsall BL
J Exp Med; 1999 Jul; 190(2):229-39. PubMed ID: 10432286
[TBL] [Abstract][Full Text] [Related]
58. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10.
Rea D; van Kooten C; van Meijgaarden KE; Ottenhoff TH; Melief CJ; Offringa R
Blood; 2000 May; 95(10):3162-7. PubMed ID: 10807783
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10.
Shurin MR; Yurkovetsky ZR; Tourkova IL; Balkir L; Shurin GV
Int J Cancer; 2002 Sep; 101(1):61-8. PubMed ID: 12209589
[TBL] [Abstract][Full Text] [Related]
60. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
